ACIPHEX, RABEPRAZOLE SODIUM, patent exp 8 th Nov 2013

New Drug Approvals

AS SODIUM SALT

Bottle of rabeprazole 20 mg tablets

ACIPHEX, RABEPRAZOLE SODIUM

Drug Patent Expiration and Exclusivity

US 5045552 – Uspto – United States Patent and Trademark Office

Active Ingredient Form Dosage Drug Type Application Product
RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE; ORAL 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** DISCN 020973 001
RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE; ORAL 20MG RX 020973 002

EISAI INC’s ACIPHEX.

Patent Expiration
US 5045552*PED 2013-11-8
US 5045552 Pyridine derivatives having anti-ulcerative activity
Pyridine derivatives useful for preventing or treating peptic ulcers, pharmaceutical preparations and methods of treating peptic ulcers are described.
2013-5-8(expired)

Exclusivity

Exclusivity is marketing rights granted by the FDA to the EISAI INC.

View original post

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s